University of Virginia Health System
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung transplants. The approach could accelerate the development of new and better treatments with more tolerable side effects than existing options.
“Oftentimes when patients are diagnosed with interstitial lung disease, they already have a lot of damage to their lungs that may not recover and limits how effective treatments can be,” said Kim, of UVA Health’s Division of Pulmonary and Critical Care. “Our goal is to identify treatments that can prevent ILD, and an important step to do this is identify adults at risk of developing this disease in the future.”
Understanding Interstitial Lung Disease…